• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非增强磁共振成像检测肝细胞癌的准确性:一项系统评价和荟萃分析。

Accuracy of Non-Contrast MRI for the Detection of Hepatocellular Carcinoma: A systematic review and meta-analysis.

作者信息

Lu Liping, Pan Xuming

机构信息

Liping Lu, Huzhou Third Municipal Hospital, the Affiliated Hospital of Huzhou University, Huzhou, Zhejiang Province, China.

Xuming Pan, Huzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Huzhou, Zhejiang Province, China.

出版信息

Pak J Med Sci. 2022 Mar-Apr;38(3Part-I):743-750. doi: 10.12669/pjms.38.3.5142.

DOI:10.12669/pjms.38.3.5142
PMID:35480538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9002405/
Abstract

Non-contrast MRI is used for identifying patients with hepatocellular carcinoma (HCC), especially among high-risk patients with cirrhosis or chronic viral hepatitis. The accuracy of non-contrast MRI has been investigated with varying results. We performed this meta-analysis to consolidate the evidence on the accuracy of non-contrast MRI for the detection of HCC. We conducted a systematic search in the databases of PubMed Central, SCOPUS, MEDLINE, EMBASE and Cochrane from inception till November 2020. We used the STATA software "Midas" package for meta-analysis. We included 15 studies with 3,756 patients. The pooled sensitivity and specificity of non-contrast MRI for HCC detection were 84% (95%CI, 78%-88%) and 94% (95%CI, 91%-97%). The positive likelihood ratio was 14.9 (95% CI, 9.0-24.7) and the negative one 0.17 (0.12-0.23). The overall quality of the studies was high. We found significant heterogeneity based on chi-square test results and I statistic > 75%. Deek's test showed the absence of publication bias. We found that non-contrast MRI has high sensitivity and specificity as a tool for detecting HCC. Studies exploring its accuracy in different ethnic populations are required to strengthen the evidence.

摘要

非增强磁共振成像(MRI)用于识别肝细胞癌(HCC)患者,尤其是在患有肝硬化或慢性病毒性肝炎的高危患者中。非增强MRI的准确性已得到研究,但结果各异。我们进行了这项荟萃分析,以巩固关于非增强MRI检测HCC准确性的证据。我们对截至2020年11月的PubMed Central、SCOPUS、MEDLINE、EMBASE和Cochrane数据库进行了系统检索。我们使用STATA软件的“Midas”包进行荟萃分析。我们纳入了15项研究,共3756名患者。非增强MRI检测HCC的合并敏感性和特异性分别为84%(95%CI,78%-88%)和94%(95%CI,91%-97%)。阳性似然比为14.9(95%CI,9.0-24.7),阴性似然比为0.17(0.12-0.23)。研究的整体质量较高。基于卡方检验结果和I统计量>75%,我们发现存在显著异质性。Deek检验显示不存在发表偏倚。我们发现非增强MRI作为检测HCC的工具具有较高的敏感性和特异性。需要开展在不同种族人群中探索其准确性的研究以加强证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94e/9002405/ab4e11ab0322/PJMS-38-743-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94e/9002405/ca9135630efb/PJMS-38-743-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94e/9002405/f0eade142364/PJMS-38-743-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94e/9002405/67f82b7aa076/PJMS-38-743-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94e/9002405/ab4e11ab0322/PJMS-38-743-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94e/9002405/ca9135630efb/PJMS-38-743-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94e/9002405/f0eade142364/PJMS-38-743-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94e/9002405/67f82b7aa076/PJMS-38-743-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94e/9002405/ab4e11ab0322/PJMS-38-743-g004.jpg

相似文献

1
Accuracy of Non-Contrast MRI for the Detection of Hepatocellular Carcinoma: A systematic review and meta-analysis.非增强磁共振成像检测肝细胞癌的准确性:一项系统评价和荟萃分析。
Pak J Med Sci. 2022 Mar-Apr;38(3Part-I):743-750. doi: 10.12669/pjms.38.3.5142.
2
Accuracy of Various Forms of Contrast-Enhanced MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.各种形式的对比增强磁共振成像诊断肝细胞癌的准确性:一项系统评价和荟萃分析
Front Oncol. 2021 Dec 7;11:680691. doi: 10.3389/fonc.2021.680691. eCollection 2021.
3
Diagnostic accuracy of fine-needle aspiration cytology for lymphoma: A systematic review and meta-analysis.细针穿刺细胞学检查对淋巴瘤的诊断准确性:系统评价和荟萃分析。
Diagn Cytopathol. 2021 Sep;49(9):975-986. doi: 10.1002/dc.24800. Epub 2021 May 18.
4
Noncontrast MRI for Hepatocellular Carcinoma Detection: A Systematic Review and Meta-analysis - A Potential Surveillance Tool?非对比 MRI 用于肝细胞癌检测:系统评价和荟萃分析 - 一种潜在的监测工具?
Clin Gastroenterol Hepatol. 2022 Jan;20(1):44-56.e2. doi: 10.1016/j.cgh.2021.02.036. Epub 2021 Mar 2.
5
Diagnostic Efficacy of Contrast-Enhanced MRI in Detecting Residual or Recurrent Hepatocellular Carcinoma After Transarterial Chemoembolization: A Systematic Review and Meta-analysis.经动脉化疗栓塞术后对比增强磁共振成像检测残余或复发性肝细胞癌的诊断效能:一项系统评价和荟萃分析
J Magn Reson Imaging. 2020 Oct;52(4):1019-1028. doi: 10.1002/jmri.26970. Epub 2019 Nov 1.
6
Computed tomography liver stiffness measurement and magnetic resonance imaging in evaluating esophageal varices in cirrhotic patients: A systematic review and meta-analysis.计算机断层扫描肝脏硬度测量和磁共振成像在评估肝硬化患者食管静脉曲张中的应用:系统评价和荟萃分析。
World J Gastroenterol. 2020 May 14;26(18):2247-2267. doi: 10.3748/wjg.v26.i18.2247.
7
Assessing the Predictive Accuracy of the aMAP Risk Score for Hepatocellular Carcinoma (HCC): Diagnostic Test Accuracy and Meta-analysis.评估甲胎蛋白异质体(aMAP)风险评分对肝细胞癌(HCC)的预测准确性:诊断试验准确性及荟萃分析
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102381. doi: 10.1016/j.jceh.2024.102381. Epub 2024 Jul 30.
8
Utility of the DECAF score for predicting survival of patients with COPD: a meta-analysis of diagnostic accuracy studies.DECAF 评分预测 COPD 患者生存的效用:诊断准确性研究的荟萃分析。
Eur Rev Med Pharmacol Sci. 2021 Jun;25(11):4037-4050. doi: 10.26355/eurrev_202106_26045.
9
Diagnostic accuracy of cardiopulmonary ultrasound for pulmonary embolism: A systematic review and meta-analysis.心肺超声诊断肺栓塞的准确性:系统评价和荟萃分析。
Echocardiography. 2022 Feb;39(2):185-193. doi: 10.1111/echo.15280. Epub 2022 Jan 13.
10
Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis.用于肝细胞癌筛查的简化 MRI:系统评价和荟萃分析。
J Hepatol. 2021 Jul;75(1):108-119. doi: 10.1016/j.jhep.2021.01.041. Epub 2021 Feb 3.

引用本文的文献

1
Geriatric nutritional risk index as a predictor of prognosis in hepatocellular carcinoma: A systematic review and meta-analysis.老年营养风险指数作为肝细胞癌预后的预测指标:一项系统评价和荟萃分析。
Pak J Med Sci. 2025 Apr;41(4):1244-1252. doi: 10.12669/pjms.41.4.11962.
2
Efficiency of indocyanine green fluorescence assisted laparoscopic hepatectomy in patients with hepatocellular carcinoma.吲哚菁绿荧光辅助腹腔镜肝切除术治疗肝细胞癌患者的疗效
Pak J Med Sci. 2025 Jan;41(1):119-124. doi: 10.12669/pjms.41.1.10626.

本文引用的文献

1
Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.钆塞酸增强简化 MRI 对肝细胞癌筛查具有高度准确性。
Eur Radiol. 2020 Nov;30(11):6003-6013. doi: 10.1007/s00330-020-07014-1. Epub 2020 Jun 25.
2
Hepatocellular Carcinoma (HCC), Where do we stand? Current situation.肝细胞癌(HCC),我们目前的状况如何?现状
Pak J Med Sci. 2020 Mar-Apr;36(3):344-348. doi: 10.12669/pjms.36.3.1594.
3
Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas.
对比在初诊肝细胞癌患者中应用钆塞酸二钠行非对比 MRI 和简化 MRI 的诊断性能:一项肝细胞癌监测的模拟研究。
Eur Radiol. 2020 Aug;30(8):4150-4163. doi: 10.1007/s00330-020-06754-4. Epub 2020 Mar 12.
4
HCC screening: assessment of an abbreviated non-contrast MRI protocol.肝细胞癌筛查:一种简化的非增强磁共振成像方案的评估
Eur Radiol Exp. 2019 Dec 18;3(1):49. doi: 10.1186/s41747-019-0126-1.
5
Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: Comparison with ultrasound.非增强磁共振成像作为肝细胞癌的监测工具:与超声的比较。
J Hepatol. 2020 Apr;72(4):718-724. doi: 10.1016/j.jhep.2019.12.001. Epub 2019 Dec 10.
6
Diagnostic performance of a minimized protocol of non-contrast MRI for hepatocellular carcinoma surveillance.非对比 MRI 最小化方案用于肝细胞癌监测的诊断性能。
Abdom Radiol (NY). 2020 Jan;45(1):211-219. doi: 10.1007/s00261-019-02277-9.
7
The Diagnostic Performance of Liver MRI without Intravenous Contrast for Detecting Hepatocellular Carcinoma: A Case-Controlled Feasibility Study.肝脏 MRI 平扫对肝细胞癌诊断效能的病例对照可行性研究。
Korean J Radiol. 2018 Jul-Aug;19(4):568-577. doi: 10.3348/kjr.2018.19.4.568. Epub 2018 Jun 14.
8
Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging.手术切除后复发性肝细胞癌的检测:非增强肝脏磁共振成像联合扩散加权成像与钆塞酸二钠增强磁共振成像的比较
Br J Radiol. 2018 Oct;91(1090):20180177. doi: 10.1259/bjr.20180177. Epub 2018 Jul 5.
9
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.肝硬化患者肝细胞癌早期检测的监测成像和甲胎蛋白:一项荟萃分析。
Gastroenterology. 2018 May;154(6):1706-1718.e1. doi: 10.1053/j.gastro.2018.01.064. Epub 2018 Feb 6.
10
Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.肝癌的影像学诊断:系统评价和荟萃分析。
Hepatology. 2018 Jan;67(1):401-421. doi: 10.1002/hep.29487. Epub 2017 Nov 29.